Skip to search formSkip to main contentSkip to account menu

R 28935

Known as: R-28935, erythro-1-(1-(2-(1,4-benzodioxan-2-yl)-2hydroxyethyl)-4-piperidyl)-2-benzimidazolinone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
The influence of various alpha-adrenoceptor antagonists (phentolamine, yohimbine, R 28935, prazosine, terazosine) on clonidine's… 
1982
1982
The intravenous administration of erythro 1-(1-[2-(1,4-benzodioxane-2-yl)-2-hydroxyethyl]-4-piperidyl)-2-benzimidazolinone R… 
1980
1980
Prazosin (3 micrograms/kg) infused prior to erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-hydroxyethyl]-4-piperidyl)-2… 
1978
1978
Summary1.The effects of erythro-1-{1-[2-(1,4-benzodioxan-2-yl)-2-hydroxyethyl]-4-piperidyl}-2-benzimidazolinone (R 28935… 
1975
1975
In the dog, erythro-1-[2-(1,4benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935) lowers the blood pressure for… 
1975
1975
Erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935), provokes marked antihypertensive… 
1975
1975
Ertyhro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-Et]-4-piperidyl)-2-benzimidazolinone (R28935), a new benzodioxanhydroxyethylpiperidyl…